相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of Simvastatin on Cetuximab Resistance in Human Colorectal Cancer With KRAS Mutations
Jeeyun Lee et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
WWP2 is an E3 ubiquitin ligase for PTEN
Subbareddy Maddika et al.
NATURE CELL BIOLOGY (2011)
PLX4032, a selective BRAFV600E kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAFWT melanoma cells
Ruth Halaban et al.
PIGMENT CELL & MELANOMA RESEARCH (2010)
RING Domain E3 Ubiquitin Ligases
Raymond J. Deshaies et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2009)
Identification of direct transcriptional targets of V600EBRAF/MEK signalling in melanoma
Leisl M. Packer et al.
PIGMENT CELL & MELANOMA RESEARCH (2009)
BRAF silencing by short hairpin RNA or chemical blockade by PLX4032 leads to different responses in melanoma and thyroid carcinoma cells
Elisa Sala et al.
MOLECULAR CANCER RESEARCH (2008)
Active-site directed probes to report enzymatic action in the ubiquitin proteasome system
Huib Ovaa
NATURE REVIEWS CANCER (2007)
Hyperactive Ras in developmental disorders and cancer
Suzanne Schubbert et al.
NATURE REVIEWS CANCER (2007)
Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas
K Fransén et al.
CARCINOGENESIS (2004)
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF
PTC Wan et al.
CELL (2004)
SPRY2 is an inhibitor of the Ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant
D Tsavachidou et al.
CANCER RESEARCH (2004)
Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis?
GA Repasky et al.
TRENDS IN CELL BIOLOGY (2004)
Mutation of B-Raf in human choroidal melanoma cells mediates cell proliferation and transformation through the MEK/ERK pathway
A Calipel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
分享论文
